Porphyria classification

	Porphyria Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Porphyria from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Porphyria classification On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Porphyria classification All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Porphyria classification
CDC on Porphyria classification
Porphyria classification in the news
Blogs on Porphyria classification
Directions to Hospitals Treating Porphyria
Risk calculators and risk factors for Porphyria classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Overview[edit | edit source]

Classification[edit | edit source]

The 8 porphyrias are:

Acute intermittent Porphyria (AIP)
ALA dehydratase deficiency
Porphyria cutanea tarda (PCT)
Congenital Erythropoetic Porphyria (CEP)
Hepatoerythropoetic Porphyria (HEP)
Erythopoetic Protoporphyria (EPP)
Hereditary coproporphyria (HCP)
Variegate Porphyria (VP)

These disorders can also be divided based on the type of precursors that accumulate and the subsequent manifestations that occur. ALA dehydratase deficiency (Plumboporphyria) and AIP are characterized by the accumulation of -aminolevulinic acid (ALA) and Porphobilinogen (PBG). Their manifestations are primarily neuropathic. PCT, CEP, HEP and EEP are characterized by accumulation of porphyrin and have cutaneous manifestations only. HCP and VP have accumulation of porphyrin precursors and porphyrins. They have both neuropathic and cutaneous manifestations.

Enzyme	Location of enzyme	Associated porphyria	Type of porphyria
δ-aminolevulinate (ALA) synthase	Mitochondrion	X-linked sideroblastic anemia (XLSA)	Erythropoietic
δ-aminolevulinate (ALA) dehydratase	Cytosol	Doss porphyria/ALA dehydratase deficiency	Hepatic
hydroxymethylbilane (HMB) synthase (or PBG deaminase)	Cytosol	acute intermittent porphyria (AIP)	Hepatic
uroporphyrinogen (URO) synthase	Cytosol	Congenital erythropoietic porphyria (CEP)	Erythropoeitic
uroporphyrinogen (URO) decarboxylase	Cytosol	Porphyria cutanea tarda (PCT)	Hepatic
coproporphyrinogen (COPRO) oxidase	Mitochondrion	Hereditary coproporphyria (HCP)	Hepatic
protoporphyrinogen (PROTO) oxidase	Mitochondrion	Variegate porphyria (VP)	Mixed
Ferrochelatase	Mitochondrion	Erythropoietic protoporphyria (EPP)	Erythropoietic

References[edit | edit source]

Template:WH Template:WS